Serum N-Telopeptide (NTx) levels may be used in predicting skeletal response (bone mineral density) to antiresorptive therapy and in monitoring bone resorption changes following initiation of antiresorptive therapy. Prior to initiating antiresorptive therapy, a serum NTx level is used to determine the probability for a decrease in bone mineral density (BMD) after one year in postmenopausal women treated with hormonal antiresorptive therapy relative to those treated with calcium supplementation.
$347.50Price for members $173.75
Preparation: Please do not exercise prior to testing. It is best that your blood is taken in a rested state.